Skip To The Main Content
Section Banner
Support OREF

Corporate Associates

OREF funds both investigator- and agenda-driven research. Agenda-driven topics are focused on a specific area of research that is particularly relevant to the field. Within its agenda-driven portfolio, OREF’s Collaborative Research Agenda (CRA) program takes a multi-partner approach to funding research. Through the CRA, OREF brings together researchers, orthopaedic surgeons, industry and other orthopaedic organizations to identify and fund research which addresses current areas of need for basic and translational research.

Current agenda-driven programs (including CRA topics) include:

  • Patient Safety
  • Trauma (CRA)
  • Youth Sports Injuries
  • Hip and Knee Arthoplasty Infection (CRA)
  • Bone Infection
  • Arthritis
  • Stem Cells
Contribute to OREF

For more information about OREF's Corporate Associates program, please contact:

Carol Wargo, MA, CAE, CFRE
Vice President, Business Development
(847) 430-5112


Corporate Associates


$200,000 to $499,999
  Arthrex
National Stem Cell Foundation
Zimmer Biomet

$100,000 to $199,999
The Aircast Foundation
MTF
MSTS logo [Converted]_recd 022411
Stryker Logo

$50,000 to $99,999
DePuySynthes Logo
Western Orthopaedic Foundation
Medacta International

$10,000 to $49,999

American Society of Anesthesiologists
Anesthesia Patient Safety Foundation
Cigna Foundation
Exactech, Inc.
Foundation for Anesthesia Education
     and Research
Ira A. Roschelle, MD Family Foundation
Pacira Pharmaceuticals
Wright Medical

$2,500 to $9,999

3M Health Care
American Arthritis Society, Inc.
Current Concepts in Joint
      Replacement® (CCJR)
Integra Foundation
Kinamed, Inc.
Orthofix
Venel